SiDOCK@Home

Message boards : Projects : SiDOCK@Home
Message board moderation

To post messages, you must log in.

AuthorMessage
Sir LanDroid

Send message
Joined: 7 Apr 13
Posts: 63
United States
Message 113462 - Posted: 27 Jan 2024, 9:45:56 UTC

Dear all, we have obtained results for different targets of SARS-CoV-2. The computations continue, and we want to ask your opinion on the next target. You can vote for one of them until February 5th, 2024.

* SARS-CoV-2 main protease (3CLpro) further studies
This is a crucial therapeutic target against SARS-CoV-2. 3CLpro (cysteine protease; EC 3.4.22.69) in particular is crucial for the cleavage of coronavirus polyproteins to form mature non-structural proteins that are themselves essential for viral replication mechanisms. We still need much more research on this target towards new more potent inhibitors.

* Ebolavirus glycoprotein (GP)
Ebola virus is a dangerous pathogen to humans and this target could be a perfect study case for PPI-type drug design scenario. The EBOV glycoprotein (GP) is the only virally expressed protein on the virion surface and is critical for attachment to host cells and catalysis of membrane fusion.

* Swine acute diarrhea syndrome coronavirus (SADS-CoV PLpro)
This target would enable us to study the design on multiple related viral targets. Swine acute diarrhea syndrome coronavirus (SADS-CoV), a newly emerging enteric coronavirus, is considered to be associated with swine acute diarrhea syndrome (SADS) which has caused significantly economic losses to the porcine industry. The pathogen indicates towards host-jump potential.

Original thread with link to vote:
https://www.sidock.si/sidock/forum_thread.php?id=268
ID: 113462 · Report as offensive

Message boards : Projects : SiDOCK@Home

Copyright © 2024 University of California.
Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation.